Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Sumida

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 20, 2022
Renaming from nonalcoholic fatty liver disease to metabolism dysfunction associated fatty liver disease: Pros and consYoshio Sumida
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 14, 2006
[Role of liver biopsy in the diagnosis of NASH]Kazuyuki Kanemasa, Yoshio Sumida
Journal of Gastroenterology|December 17, 2017
Current and future pharmacological therapies for NAFLD/NASHYoshio Sumida, Masashi Yoneda
Internal Medicine (Tokyo, Japan)|December 28, 2017
Glycogen Hepatopathy: An Under-recognized Hepatic Complication of Uncontrolled Type 1 Diabetes MellitusYoshio Sumida, Masashi Yoneda
Journal of Gastroenterology|July 2, 2021
COVID-19-associated liver injury (COVALI): role of hepatologistsYoshio Sumida, Masashi Yoneda
World Journal of Gastroenterology|February 28, 2014
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisYoshio Sumida, Atsushi Nakajima, Yoshito Itoh
Hepatobiliary Surgery and Nutrition|December 10, 2020
Automated quantification of fibrosis-related parameters using dual-photon microscopy replace diagnosis of pathologists in NAFLDYoshio Sumida, Takeshi Okanoue, Atsushi Nakajima, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 9, 2016
[Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: VII. Routine treatment: when referring to specialists]Yoshio Sumida, Yuya Seko, Yoshito Itoh
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 10, 2019
Phase 3 drug pipelines in the treatment of non-alcoholic steatohepatitisYoshio Sumida, Takeshi Okanoue, Atsushi Nakajima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 27, 2016
Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitusYoshio Sumida, Yuya Seko, Masashi Yoneda, et al.
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 20, 2022
Renaming from nonalcoholic fatty liver disease to metabolism dysfunction associated fatty liver disease: Pros and consYoshio Sumida
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 14, 2006
[Role of liver biopsy in the diagnosis of NASH]Kazuyuki Kanemasa, Yoshio Sumida
Journal of Gastroenterology|December 17, 2017
Current and future pharmacological therapies for NAFLD/NASHYoshio Sumida, Masashi Yoneda
Internal Medicine (Tokyo, Japan)|December 28, 2017
Glycogen Hepatopathy: An Under-recognized Hepatic Complication of Uncontrolled Type 1 Diabetes MellitusYoshio Sumida, Masashi Yoneda
Journal of Gastroenterology|July 2, 2021
COVID-19-associated liver injury (COVALI): role of hepatologistsYoshio Sumida, Masashi Yoneda
World Journal of Gastroenterology|February 28, 2014
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisYoshio Sumida, Atsushi Nakajima, Yoshito Itoh
Hepatobiliary Surgery and Nutrition|December 10, 2020
Automated quantification of fibrosis-related parameters using dual-photon microscopy replace diagnosis of pathologists in NAFLDYoshio Sumida, Takeshi Okanoue, Atsushi Nakajima, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 9, 2016
[Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: VII. Routine treatment: when referring to specialists]Yoshio Sumida, Yuya Seko, Yoshito Itoh
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 10, 2019
Phase 3 drug pipelines in the treatment of non-alcoholic steatohepatitisYoshio Sumida, Takeshi Okanoue, Atsushi Nakajima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 27, 2016
Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitusYoshio Sumida, Yuya Seko, Masashi Yoneda, et al.
Pageof 22